These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14946328)

  • 1. Homotypic complement-fixing antibody in monkeys infected with type 2 poliomyelitis virus by the oral route.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):55-8. PubMed ID: 14946328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies.
    MELNICK JL; KAPLAN AS
    J Exp Med; 1953 Mar; 97(3):367-400. PubMed ID: 13052807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.
    WINSSER J; SABIN AB
    J Exp Med; 1952 Nov; 96(5):477-90. PubMed ID: 13000058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):35-53. PubMed ID: 14946327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types.
    SABIN AB; HENNESSEN WA; WINSSER J
    J Exp Med; 1954 Jun; 99(6):551-76. PubMed ID: 13163327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus.
    SABIN AB
    J Exp Med; 1952 Jul; 96(1):99-106. PubMed ID: 14946332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific complement-fixation test for infection with poliomyelitis virus.
    CASALS J; OLITSKY PK; ANSLOW RO
    J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.
    GOLDBLUM N; MELNICK JL
    J Exp Med; 1952 Aug; 96(2):175-85. PubMed ID: 14955573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ohio strains of a virus pathogenic for infant mice, Coxsackie group; simultaneous occurrence with poliomyelitis virus in patients with summer grippe.
    MELNICK JL; LEDINKO N
    J Exp Med; 1950 Feb; 91(2):185-95. PubMed ID: 15409906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of human interferon to rabies virus-infected monkeys after exposure.
    Hilfenhaus J; Weinmann E; Majer M; Barth R; Jaeger O
    J Infect Dis; 1977 May; 135(5):846-9. PubMed ID: 404370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis.
    Shen L; Chen CY; Huang D; Wang R; Zhang M; Qian L; Zhu Y; Zhang AZ; Yang E; Qaqish A; Chumakov K; Kouiavskaia D; Vignuzzi M; Nathanson N; Macadam AJ; Andino R; Kew O; Xu J; Chen ZW
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28356537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliomyelitis as a complex infection.
    DALLDORF G; WEIGAND H
    J Exp Med; 1958 Nov; 108(5):605-16. PubMed ID: 13587845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.
    STEIGMAN AJ; SABIN AB
    J Exp Med; 1949 Oct; 90(4):349-72. PubMed ID: 18140667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection induced by oral administration of attenuated poliovirus to persons possessing homotypic antibody.
    HORSTMANN DM; PAUL JR; MELNICK JL; DEUTSCH JV
    J Exp Med; 1957 Jul; 106(1):159-77. PubMed ID: 13439122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STUDIES IN RODENT POLIOMYELITIS : III. EXPERIMENTAL POLIOMYELITIS IN GUINEA PIGS PRODUCED WITH THE MURINE STRAIN OF SK POLIOMYELITIS VIRUS.
    Jungeblut CW; Feiner RR; Sanders M
    J Exp Med; 1942 Jul; 76(1):31-51. PubMed ID: 19871219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies on passive immunization against poliomyelitis. II. The prophylactic effect of human gamma globulin on paralytic poliomyelitis in cynomolgus monkeys after virus feeding.
    BODIAN D
    Am J Hyg; 1952 Jul; 56(1):78-89. PubMed ID: 14933392
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of neutralizing antibody for a year following vaccination of monkeys with Lansing poliomyelitis virus.
    MORGAN IM
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):305-8. PubMed ID: 14808241
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis.
    Zhang YJ; Ohman P; Putkonen P; Albert J; Walther L; Stålhandske P; Biberfeld G; Fenyö EM
    Virology; 1993 Dec; 197(2):609-15. PubMed ID: 7902628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of neutralizing antibody in monkeys injected with poliomyelitis virus and adjuvants.
    WARD R; RADER D; LIPTON MM; FREUND J
    Proc Soc Exp Biol Med; 1950 Jul; 74(3):536-9. PubMed ID: 15440879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.